Atabak Mokari insider trades

Open-market stock purchases and sales by Atabak Mokari, Chief Financial Officer at Corcept Therapeutics Inc, from SEC Form 4 filings since Jul 27, 2016.

Recent trades

DateStockTradeValue
Jun 15, 2026CORT Corcept Therapeutics IncSold$755K
Jun 15, 2026CORT Corcept Therapeutics IncSold$897K
Jun 15, 2026CORT Corcept Therapeutics IncSold$1.6M
Jun 15, 2026CORT Corcept Therapeutics IncSold$165
Jun 15, 2026CORT Corcept Therapeutics IncBought (not open market)—
Jun 2, 2026CORT Corcept Therapeutics IncSold (not open market)$27.8K
Jun 1, 2026CORT Corcept Therapeutics IncSold$2.8M
Jun 1, 2026CORT Corcept Therapeutics IncBought (not open market)—
Jun 1, 2026CORT Corcept Therapeutics IncBought (not open market)—
Mar 3, 2026CORT Corcept Therapeutics IncSold (not open market)$3.5K
Mar 2, 2026CORT Corcept Therapeutics IncBought (not open market)—
Feb 27, 2026CORT Corcept Therapeutics IncBought (not open market)—
Dec 2, 2025CORT Corcept Therapeutics IncSold (not open market)$9.4K
Dec 1, 2025CORT Corcept Therapeutics IncBought (not open market)—

Companies traded

  • CORT Corcept Therapeutics Inc: 5 sales, last Jun 15, 2026
  • BLCM Bellicum Pharmaceuticals, Inc: other filings, last Apr 8, 2020
  • IRIX Iridex Corp: other filings, last Dec 11, 2018

Get free alerts when Atabak Mokari files a new trade →